Skip to main content

Advertisement

Log in

Reduction of serum level of interleukin-2 and pruritus severity after acupuncture at Quchi (LI11) in hemodialysis patients: a placebo-controlled randomized clinical trial

针刺曲池穴降低血液透析患者血清白介素2和瘙痒: 安慰剂随机对照临床试验

  • Clinical Study
  • Published:
Journal of Acupuncture and Tuina Science Aims and scope Submit manuscript

Abstract

Objective

To observe the effect of acupuncture at Quchi (LI11) on the serum interleukin-2 (IL-2) level and the severity of uremic pruritus (UP) in hemodialysis patients.

Methods

Sixty hemodialysis patients with UP were randomized into an acupuncture group and a control group, with 30 cases in each group. In the acupuncture group, patients were treated with acupuncture at Quchi (LI11) twice a week for six weeks. In the control group, each patient received a placebo treatment (sham acupuncture). Before and after the intervention, the pruritis severity was examined using a 5-D scale, and the serum IL-2 level was measured using an enzyme-linked immunosorbent assay kit.

Results

There were no statistically significant differences in the demographic or clinical factors between the control group and the acupuncture group at baseline. The reduction in pruritus severity in patients was more significant in the acupuncture group (P=0.027). Acupuncture therapy also significantly decreased the serum IL-2 level in the patients (P=0.011). Throughout the acupuncture procedures, the incidence of pain and mild bleeding was 3.6% and 2.5%, respectively.

Conclusion

Six-week acupuncture treatment at Quchi (LI11) can effectively decrease the severity of UP and the serum IL-2 level. Large-scale, long-duration, and multi-center studies are needed to fully understand the role of IL-2 in inflammation and neuroimmune stimulation during acupuncture.

【摘要】

目的

观察针刺曲池穴对血液透析患者血清白细胞介素2(IL-2)水平及尿毒症瘙痒(UP)程度的影响。

方法

将60例尿素症瘙痒的血液透析患者随机分为针刺组和对照组, 每组30例。针刺组患者接受针刺曲池治疗, 每周2次, 共治疗6周。对照组患者接受安慰剂治疗(假针刺)。干预前后用5-D量表评价瘙痒程度, 用酶联免疫吸附测定试剂盒检测血清IL-2水平。

结果

在人口统计及临床因素方面对照组与针刺组基线数据无统计学差异。针刺组患者的瘙痒减轻程度明显高于对照组(P=0.027)。同时, 针刺疗法能显著降低血清IL-2水平(P=0.011)。全部针刺过程中, 疼痛和轻微出血的发生率分别为3.6%和2.5%。

结论

针刺曲池6周有效地降低了UP严重程度及血清IL-2水平。为全面了解针刺时IL-2在炎症和神经免疫刺激中的作用, 需要开展大样本、长周期、多中心的研究。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. PISONI R L, WIKSTRÖM B, ELDER S J, AKIZAWA T, ASANO Y, KEEN M L, SARAN R, MENDELSSOHN D C, YOUNG E W, PORT F K. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant, 2006, 21(12): 3495–3505.

    Article  PubMed  Google Scholar 

  2. MATHUR V S, LINDBERG J, GERMAIN M, BLOCK G, TUMLIN J, SMITH M, GREWAL M, MCGUIRE D; ITCH National Registry Investigators. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol, 2010, 5(8): 1410–1419.

    Article  PubMed  PubMed Central  Google Scholar 

  3. ARAMWIT P, OUPPATHAM S. Uremic Pruritus: Its Prevalence, Pathophysiology and Management. Updates in Hemodialysis. London: IntechOpen Limited, 2015: 19–42.

    Google Scholar 

  4. SHIRAZIAN S, AINA O, PARK Y, CHOWDHURY N, LEGER K, HOU L, MIYAWAKI N, MATHUR V S. Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis, 2017, 10: 11–26.

    Article  PubMed  PubMed Central  Google Scholar 

  5. MIHAI S, CODRICI E, POPESCU I D, ENCIU A M, ALBULESCU L, NECULA L G, MAMBET C, ANTON G, TANASE C. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res, 2018, 2018: 2180373.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. AMORE A, COPPO R. Immunological basis of inflammation in dialysis. Nephrol Dial Transplant, 2002, Suppl 8: 16–24.

  7. METTANG T, PAULI-MAGNUS C, ALSCHER D M. Uraemic pruritus-new perspectives and insights from recent trials. Nephrol Dial Transplant, 2002, 17(9): 1558–1563.

    Article  PubMed  Google Scholar 

  8. DILLON S R, SPRECHER C, HAMMOND A, BILSBOROUGH J, ROSENFELD-FRANKLIN M, PRESNELL S R, HAUGEN H S, MAURER M, HARDER B, JOHNSTON J, BORT S, MUDRI S, KUIJPER J L, BUKOWSKI T, SHEA P, DONG D L, DASOVICH M, GRANT F J, LOCKWOOD L, LEVIN S D, LECIEL C, WAGGIE K, DAY H, TOPOUZIS S, KRAMER J, KUESTNER R, CHEN Z, FOSTER D, PARRISH-NOVAK J, GROSS J A. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol, 2004, 5(7): 752–760.

    Article  CAS  PubMed  Google Scholar 

  9. YOSIPOVITCH G, DUQUE M I, PATEL T S, ISHIUJI Y, GUZMAN-SANCHEZ D A, DAWN A G, FREEDMAN B I, CHAN Y H, CRUMRINE D, ELIAS P M. Skin barrier structure and function and their relationship to pruritus in end-stage renal disease. Nephrol Dial Transplant, 2007, 22(11): 3268–3272.

    Article  PubMed  Google Scholar 

  10. COMBS S A, TEIXEIRA J P, GERMAIN M J. Pruritus in kidney disease. Semin Nephrol, 2015, 35(4): 383–391.

    Article  PubMed  PubMed Central  Google Scholar 

  11. WAHLGREN C F, TENGVALL LINDER M, HÄGERMARK O, SCHEYNIUS A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res, 1995, 287(6): 572–580.

    Article  CAS  PubMed  Google Scholar 

  12. NAKAMURA M, TOYODA M, MOROHASHI M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol, 2003, 149(4): 718–730.

    Article  CAS  PubMed  Google Scholar 

  13. GASPARI A A, LOTZE M T, ROSENBERG S A, STERN J B, KATZ S I. Dermatologic changes associated with interleukin 2 administration. JAMA, 1987, 258(12): 1624–1629.

    Article  CAS  PubMed  Google Scholar 

  14. IKOMA A, STEINHOFF M, STÄNDER S, YOSIPOVITCH G, SCHMELZ M. The neurobiology of itch. Nat Rev Neurosci, 2006, 7(7): 535–547.

    Article  CAS  PubMed  Google Scholar 

  15. CARR M N, TORRES S M, KOCH S N, REITER L V. Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs. Vet Dermatol, 2009, 20(2): 105–110.

    Article  PubMed  Google Scholar 

  16. BUDDENKOTTE J, STEINHOFF M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy, 2010, 65(7): 805–821.

    Article  CAS  PubMed  Google Scholar 

  17. NOWAK D A, YEUNG J. Diagnosis and treatment of pruritus. Can Fam Physician, 2017, 63(12): 918–924.

    PubMed  PubMed Central  Google Scholar 

  18. NARITA I, IGUCHI S, OMORI K, GEJYO F. Uremic pruritus in chronic hemodialysis patients. J Nephrol, 2008, 21(2): 161–165.

    PubMed  Google Scholar 

  19. METTANG T, KREMER A E. Uremic pruritus. Kidney Int, 2015, 87(4): 685–691.

    Article  CAS  PubMed  Google Scholar 

  20. LEE H C, PARK S Y. Preliminary comparison of the efficacy and safety of needle-embedding therapy with acupuncture for atopic dermatitis patients. Evid Based Complement Alternat Med, 2019, 2019: 6937942.

    PubMed  PubMed Central  Google Scholar 

  21. WANG Z, CHEN T, LONG M, CHEN L, WANG L, YIN N, CHEN Z. Electro-acupuncture at acupoint ST36 ameliorates inflammation and regulates Th1/Th2 balance in delayed-type hypersensitivity. Inflammation, 2017, 40(2): 422–434.

    Article  CAS  PubMed  Google Scholar 

  22. LAN L, TAO J, CHEN A, XIE G, HUANG J, LIN J, PENG J, CHEN L. Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-κB pathway. Int J Mol Med, 2013, 31(1): 75–80.

    Article  CAS  PubMed  Google Scholar 

  23. GAO H, ZHANG W, WANG Y. Acupuncture treatment for 34 cases of uremic cutaneous pruritus. J Tradit Chin Med, 2002, 22(1): 29–30.

    PubMed  Google Scholar 

  24. CHOU C Y, CHENG Y W, KAO M T, HUANG C C. Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant, 2005, 20(9): 1912–1915.

    Article  Google Scholar 

  25. PHAN F A, SRILESTARI A, MIHARDJA H, MARBUN M B H. Effects of acupuncture on uremic pruritus in patients undergoing hemodialysis. J Phys Conf Ser, 2018, 1073: 062049.

    Article  CAS  Google Scholar 

  26. KIM K H, LEE M S, CHOI S M. Acupuncture for treating uremic pruritus in patients with end-stage renal disease: a systematic review. J Pain Symptom Manage, 2010, 40(1): 117–125.

    Article  PubMed  Google Scholar 

  27. MACPHERSON H, ALTMAN D G, HAMMERSCHLAG R, LI Y, WU T, WHITE A, MOHER D; STRICTA Revision Group. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med, 2010, 3(3): 140–155.

    Article  PubMed  Google Scholar 

  28. ELMAN S, HYNAN L S, GABRIEL V, MAYO M J. The 5-D itch scale: a new measure of pruritus. Br J Dermatol, 2010, 162(3): 587–593.

    Article  CAS  PubMed  Google Scholar 

  29. FILSHIE J, WHITE A, CUMMINGS M. Medical Acupuncture: A Western Scientific Approach. 2nd Edition. London: Elsevier Ltd., 2016.

    Google Scholar 

  30. KIM J, OH H J, YOON S P. A cadaveric study of needle insertion at LI11. Acupunct Med, 2015, 33(6): 497–499.

    Article  PubMed  Google Scholar 

  31. YU C, ZHANG P, LÜ Z T, LI J J, LI H P, WU C H, GAO F, YUAN X C, ZHANG J, HE W, JING X H, LI M. Efficacy of acupuncture in itch: a systematic review and meta-analysis of clinical randomized controlled trials. Evid Based Complement Alternat Med, 2015, 2015: 208690.

    PubMed  PubMed Central  Google Scholar 

  32. WONG E L, LEUNG P C, ZHANG L. Placebo acupuncture in an acupuncture clinical trial. How good is the blinding effect?. J Acupunct Meridian Stud, 2015, 8(1): 40–43.

    Article  PubMed  Google Scholar 

  33. PFAB F, HAMMES M, BÄCKER M, HUSS-MARP J, ATHANASIADIS G I, TÖLLE T R, BEHRENDT H, RING J, DARSOW U. Preventive effect of acupuncture on histamine-induced itch: a blinded, randomized, placebo-controlled, crossover trial. J Allergy Clin Immunol, 2005, 116(6): 1386–1388.

    Article  CAS  PubMed  Google Scholar 

  34. QI Y Z. Unexpected massive cutaneous pruritus treated by acupuncture. World J Acupunct Moxibustion, 2012, 22(4): 65–66.

    Article  Google Scholar 

  35. KARJALIAN F, MOMENNASAB M, YOOSEFINEJAD A K, JAHROMI S E. The effect of acupressure on the severity of pruritus and laboratory parameters in patients undergoing hemodialysis: a randomized clinical trial. J Acupunct Meridian Stud, 2020, 13(4): 117–123.

    Article  PubMed  Google Scholar 

  36. KUMAR K, SINGH S. Neuraxial opioid-induced pruritus: an update. J Anaesthesiol Clin Pharmacol, 2013, 29(3): 303–307.

    Article  PubMed  PubMed Central  Google Scholar 

  37. DASHTDAR M, DASHTDAR M R, DASHTDAR B, KARDI K, SHIRAZI M K. The concept of wind in traditional Chinese medicine. J Pharmacopuncture, 2016, 19(4): 293–302.

    Article  PubMed  PubMed Central  Google Scholar 

  38. WU J, HU Y, ZHU Y, YIN P, LITSCHER G, XU S. Systematic review of adverse effects: a further step towards modernization of acupuncture in China. Evid Based Complement Alternat Med, 2015, 2015: 432467.

    PubMed  PubMed Central  Google Scholar 

  39. PARK H, KIM K. Isolated common femoral artery injury resulting from blunt military trauma. Mil Med, 2018, 183(11–12): e758–e761.

    Article  PubMed  Google Scholar 

  40. QI Y C, XIAO X J, DUAN R S, YUE Y H, ZHANG X L, LI J T, LI Y Z. Effect of acupuncture on inflammatory cytokines expression of spastic cerebral palsy rats. Asian Pac J Trop Med, 2014, 7(6): 492–495.

    Article  CAS  PubMed  Google Scholar 

  41. PAVLOV V A, TRACEY K J. Neural circuitry and immunity. Immunol Res, 2015, 63(1): 38–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. ZIA S, NDOYE A, LEE T X, WEBBER R J, GRANDO S A. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther, 2000, 293(3): 973–981.

    CAS  PubMed  Google Scholar 

  43. KAWASHIMA K, YOSHIKAWA K, FUJII YX, MORIWAKI Y, MISAWA H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci, 2007, 80(24): 2314–2319.

    Article  CAS  PubMed  Google Scholar 

  44. PARRISH W R, ROSAS-BALLINA M, GALLOWITSCH-PUERTA M, OCHANI M, OCHANI K, YANG LH, HUDSON L, LIN X, PATEL N, JOHNSON S M, CHAVAN S, GOLDSTEIN R S, CZURA C J, MILLER E J, AL-ABED Y, TRACEY K J, PAVLOV V A. Modulation of TNF release by choline requires alpha 7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med, 2008, 14(9–10): 567–574.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. DA SILVA M D, GUGINSKI G, WERNER M F, BAGGIO C H, MARCON R, SANTOS A R. Involvement of interleukin-10 in the anti-inflammatory effect of Sanyinjiao (SP6) acupuncture in a mouse model of peritonitis. Evid Based Complement Alternat Med, 2011, 2011: 217946.

    Article  PubMed  PubMed Central  Google Scholar 

  46. CAPOBIANCO M, CASSIANO G, FURINI A, STORTI-MELO L, BONINI C, DANTAS MACHADO RL. Human interleukin 2 (IL-2) promotion of immune regulation and clinical outcomes: a review. J Cytok Bio, 2016, 1: 2.

    Google Scholar 

  47. FANG J Q, LIU F, SHAO X M, WU Y Y. Effect of electroacupuncture on carrageenan-induced inflammation, IL-1beta and TNF-alpha concentrations and their mRNA expressions in toe tissue in rats. Zhen Ci Yan Jiu, 2007, 32(4): 224–228.

    PubMed  Google Scholar 

  48. PARK J Y, PARK H J, CHOI Y Y, KIM M H, KIM S N, YANG W M. Effects of acupuncture on 1-chloro-2, 4-dinitrochlorobenzene-induced atopic dermatitis. Evid Based Complement Alternat Med, 2013, 2013: 982095.

    PubMed  PubMed Central  Google Scholar 

  49. WU M, CUI J, XU D, ZHANG K, JING X, BAI W. Neuroanatomical characteristics of deep and superficial needling using LI11 as an example. Acupunct Med, 2015, 33(6): 472–477.

    Article  PubMed  PubMed Central  Google Scholar 

  50. ERNST E, WHITE A R. Prospective studies of the safety of acupuncture: a systematic review. Am J Med, 2001, 110(6): 481–485.

    Article  CAS  PubMed  Google Scholar 

  51. TEY H L, WALLENGREN J, YOSIPOVITCH G. Psychosomatic factors in pruritus. Clin Dermatol, 2013, 31(1): 31–40.

    Article  PubMed  PubMed Central  Google Scholar 

  52. ZASLAWSKI C, ROGERS C, GARVEY M, RYAN D, YANG C X, ZHANG S P. Strategies to maintain the credibility of sham acupuncture used as a control treatment in clinical trials. J Altern Complement Med, 1997, 3(3): 257–266.

    Article  CAS  PubMed  Google Scholar 

  53. LUND I, NÄSLUND J, LUNDEBERG T. Minimal acupuncture is not a valid placebo control in randomised controlled trials of acupuncture: a physiologist’s perspective. Chin Med, 2009, 4: 1.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the editors of Editverse (www.editverse.com) for their help in manuscript editing and formatting.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dedi Ardinata.

Additional information

Conflict of Interest

The authors declare that there is no potential conflict of interest in this article.

Statement of Informed Consent

Informed consent was obtained from all individual participants.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ardinata, D., Zain-Hamid, R., Mahadi, I.D. et al. Reduction of serum level of interleukin-2 and pruritus severity after acupuncture at Quchi (LI11) in hemodialysis patients: a placebo-controlled randomized clinical trial. J. Acupunct. Tuina. Sci. 20, 126–133 (2022). https://doi.org/10.1007/s11726-022-1299-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11726-022-1299-3

Keywords

【关键词】

【中图分类号】

【文献标志码】

Navigation